These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


129 related items for PubMed ID: 33470774

  • 21. Evaluation of bacille Calmette-Guérin immunisation programs in Australia.
    Khandaker G, Beard FH, Dey A, Coulter C, Hendry AJ, Macartney KK.
    Commun Dis Intell Q Rep; 2017 Mar 31; 41(1):E33-E48. PubMed ID: 28385137
    [Abstract] [Full Text] [Related]

  • 22. No adverse events after simultaneous administration of 50 000 IU vitamin A and Bacille Calmette-Guerin vaccination to normal-birth-weight newborns in Guinea-Bissau.
    Nante JE, Diness BR, Ravn H, Roth A, Aaby P, Benn CS.
    Eur J Clin Nutr; 2008 Jul 31; 62(7):842-8. PubMed ID: 17538544
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. The effect of bacille Calmette-Guérin vaccination at birth on immune response in China.
    Pang Y, Kang W, Zhao A, Liu G, Du W, Xu M, Wang G, Zhao Y, Zheng S.
    Vaccine; 2015 Jan 01; 33(1):209-13. PubMed ID: 25454854
    [Abstract] [Full Text] [Related]

  • 25. The role of BCG vaccine in the prevention and control of tuberculosis in the United States. A joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices.
    MMWR Recomm Rep; 1996 Apr 26; 45(RR-4):1-18. PubMed ID: 8602127
    [Abstract] [Full Text] [Related]

  • 26. Serious adverse events associated with bacille Calmette-Guérin vaccine in Canada.
    Deeks SL, Clark M, Scheifele DW, Law BJ, Dawar M, Ahmadipour N, Walop W, Ellis CE, King A.
    Pediatr Infect Dis J; 2005 Jun 26; 24(6):538-41. PubMed ID: 15933565
    [Abstract] [Full Text] [Related]

  • 27. Adverse reaction to Bacille-Calmette-Guérin vaccine in a HIV positive healthcare worker.
    Garvey JF, Gueret P, McDonnell TJ.
    Ir J Med Sci; 2007 Sep 26; 176(3):237-8. PubMed ID: 17701437
    [Abstract] [Full Text] [Related]

  • 28. The influence of bacille Calmette-Guerin vaccine strain on the immune response against tuberculosis: a randomized trial.
    Ritz N, Dutta B, Donath S, Casalaz D, Connell TG, Tebruegge M, Robins-Browne R, Hanekom WA, Britton WJ, Curtis N.
    Am J Respir Crit Care Med; 2012 Jan 15; 185(2):213-22. PubMed ID: 22071384
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Dose of Calmette-Guérin bacillus vaccination in infants.
    Gür E, Arvas A.
    Pediatr Infect Dis J; 2002 Apr 15; 21(4):359-60. PubMed ID: 12075777
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Treating BCG-induced disease in children.
    Cuello-García CA, Pérez-Gaxiola G, Jiménez Gutiérrez C.
    Cochrane Database Syst Rev; 2013 Jan 31; 2013(1):CD008300. PubMed ID: 23440826
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Criteria for discontinuation of vaccination programmes using Bacille Calmette-Guerin (BCG) in countries with a low prevalence of tuberculosis. A statement of the International Union Against Tuberculosis and Lung Disease.
    Tuber Lung Dis; 1994 Jun 31; 75(3):179-80. PubMed ID: 7919307
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Urinary bladder tuberculosis and Bacillus Calmette-Guérin instillation: reduced efficacy of bisoprolol in hypertension].
    Drechsler A, Kirch W.
    Dtsch Med Wochenschr; 2010 Oct 31; 135(40):1968-70. PubMed ID: 20922637
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.